title: Comparison of infarct volume and behavioral deficit in Wistar Kyoto and spontaneously hypertensive rat after transient occlusion of the middle cerebral artery.
abstract: Rodent models of focal cerebral ischemia are important tools in experimental stroke research. Such models have proven instrumental for the understanding of injury mechanisms in cerebral stroke and helped to identify potential new therapeutic options. A plethora of neuroprotective substances have been shown to be effective in preclinical stroke research but failed to prove effectiveness in subsequent clinical trials. Interestingly, preclinical studies have shown that neuroprotective agents are selectively effective in different rat strains. The underlying mechanisms for this discrepancy are so far unknown, but differences in initial stroke volume with concomitant neuroinflammatory processes in the expanding stroke area might be relevant. In the current project, we compared the stroke volume and behavioral outcome between Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHR), subjected to transient middle cerebral artery occlusion (tMCAO) for 1 h, followed by 23 h reperfusion. We further analyzed the expression of well-known pro-inflammatory mediators in the cortical peri-infarct area region using a TTC-based isolation approach. Initial reduction of local cerebral blood flow was comparable between both strains. Mean infarct volume and the extent of tMCAO-provoked functional deficits did not differ between WKY and SHR rats. Furthermore, the induction of pro-inflammatory mediators, among CCL3 and CCL5, in the isolated ischemic peri-infarct area region was equal in both rat strains. We were able to demonstrate that stroke outcome is comparable 23 h after transient MCAO in WKY and SHR rats. Future studies have to show whether this observation confirms in the long-term, and which factors contribute to differences observed with respect to therapeutic responsiveness.
authors.affiliation: Institute of Neuroanatomy, Faculty of Medicine, RWTH Aachen University, Wendlingweg 2, 52074 Aachen, Germany.
authors.forename: Jorge
authors.initials: J
authors.lastname: Garcia
authors.forename: Jon
authors.initials: J
authors.lastname: Dang
authors.forename: Pardes
authors.initials: P
authors.lastname: Habib
authors.forename: Cordian
authors.initials: C
authors.lastname: Beyer
authors.forename: Markus
authors.initials: M
authors.lastname: Kipp
keywords: Behavior; SHR; Stroke; WKY; Wistar; tMCAO
references.citation: Am J Physiol Regul Integr Comp Physiol. 2007 May;292(5):R1881-92
references.pmid: 17234953
references.citation: Stroke. 1995 Jun;26(6):1072-8
references.pmid: 7762026
references.citation: Exp Transl Stroke Med. 2009 Nov 25;1:8
references.pmid: 20150986
references.citation: J Neuroendocrinol. 2011 Jul;23(7):601-11
references.pmid: 21507085
references.citation: Exp Brain Res. 2013 Jan;224(2):155-64
references.pmid: 23064810
references.citation: J Neurosci Methods. 2008 Feb 15;168(1):1-7
references.pmid: 18029024
references.citation: CNS Neurosci Ther. 2012 Oct;18(10):834-40
references.pmid: 22925047
references.citation: J Cereb Blood Flow Metab. 2010 Aug;30(8):1520-6
references.pmid: 20407464
references.citation: Neurology. 2012 Sep 25;79(13 Suppl 1):S79-85
references.pmid: 23008418
references.citation: Brain Res. 2010 Apr 22;1326:1-14
references.pmid: 20176000
references.citation: Cell Mol Neurobiol. 2004 Oct;24(5):589-98
references.pmid: 15485133
references.citation: Cerebrovasc Dis. 2012;33(1):23-9
references.pmid: 22133698
references.citation: Stroke. 1996 Sep;27(9):1616-22; discussion 1623
references.pmid: 8784138
references.citation: AJNR Am J Neuroradiol. 1997 Sep;18(8):1435-45
references.pmid: 9296184
references.citation: Acta Neuropathol. 2009 May;117(5):497-509
references.pmid: 19225790
references.citation: Atherosclerosis. 1977 Nov;28(3):217-22
references.pmid: 23130
references.citation: Ann Neurol. 2007 May;61(5):396-402
references.pmid: 17420989
references.citation: Br J Pharmacol. 2008 Mar;153 Suppl 1:S325-38
references.pmid: 18059324
references.citation: Brain Behav Immun. 2011 May;25(4):715-26
references.pmid: 21277368
references.citation: Cerebrovasc Dis. 2006;22(5-6):429-31
references.pmid: 16912477
references.citation: J Steroid Biochem Mol Biol. 2012 Aug;131(1-2):10-6
references.pmid: 22326729
references.citation: Stroke. 2001 Nov;32(11):2559-66
references.pmid: 11692017
references.citation: Stroke. 1995 Apr;26(4):627-34; discussion 635
references.pmid: 7709410
references.citation: J Magn Reson Imaging. 2005 Apr;21(4):340-6
references.pmid: 15778949
references.citation: Am J Med Sci. 1993 Nov;306(5):282-6
references.pmid: 8238081
references.citation: Acta Neurochir Suppl (Wien). 1994;60:282-4
references.pmid: 7976568
references.citation: CNS Neurosci Ther. 2012 Nov;18(11):903-8
references.pmid: 22978829
references.citation: J Cereb Blood Flow Metab. 1988 Aug;8(4):449-61
references.pmid: 2968987
references.citation: Glia. 2009 Jun;57(8):807-14
references.pmid: 19031445
references.citation: Neurochem Int. 2009 Dec;55(7):610-8
references.pmid: 19524632
references.citation: J Neurosci Methods. 2010 Mar 15;187(1):84-9
references.pmid: 20064557
references.citation: J Cereb Blood Flow Metab. 2011 Dec;31(12):e1-8
references.pmid: 21971350
references.citation: N Engl J Med. 1995 Dec 14;333(24):1581-7
references.pmid: 7477192
references.citation: Prog Histochem Cytochem. 1976;9(3):1-56
references.pmid: 792958
references.citation: J Neuroinflammation. 2012 Apr 25;9:76
references.pmid: 22533966
references.citation: J Cereb Blood Flow Metab. 2012 Sep;32(9):1765-77
references.pmid: 22669479
references.citation: Brain. 2009 Jun;132(Pt 6):1480-95
references.pmid: 19359287
references.citation: Stroke. 2000 Aug;31(8):1965-72; discussion 1972-3
references.pmid: 10926965
references.citation: J Mol Neurosci. 2008 Jun;35(2):235-43
references.pmid: 18373222
references.citation: J Cereb Blood Flow Metab. 2013 Mar;33(3):356-64
references.pmid: 23149556
references.citation: J Cereb Blood Flow Metab. 2004 Mar;24(3):298-304
references.pmid: 15091110